Cellectar Biosciences
$2.5
54
-$0.04-1.57% Today
Statistics
Day High
2.71
Day Low
2.43
52W High
20.7
52W Low
2.43
Volume
26,360
Avg. Volume
69,132
Mkt Cap
7.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-1.885
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-89.16MNet Income
Analyst Ratings
$10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CLRB. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Adc Therapeutics SA
ADCT
Mkt Cap501.75M
Allogene Therapeutics
ALLO
Mkt Cap275.13M
Gilead Sciences
GILD
Mkt Cap148.78B
Novartis
NVS
Mkt Cap237.61B
AMGEN
AMGN
Mkt Cap160.66B
About
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Show more...
CEO
Mr. James V. Caruso
Employees
11
Country
US
ISIN
US15117F8804
Listings
0 Comments
Share your thoughts
FAQ
What is Cellectar Biosciences stock price today?▼
The current price of CLRB is $2.5 USD — it has decreased by -1.57% in the past 24 hours. Watch Cellectar Biosciences stock price performance more closely on the chart.
What is Cellectar Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellectar Biosciences stocks are traded under the ticker CLRB.
Is Cellectar Biosciences stock price growing?▼
CLRB stock has fallen by -15.25% compared to the previous week, the month change is a -22.96% fall, over the last year Cellectar Biosciences has showed a +756.16% increase.
What is Cellectar Biosciences market cap?▼
Today Cellectar Biosciences has the market capitalization of 7.98M
When is the next Cellectar Biosciences earnings date?▼
Cellectar Biosciences is going to release the next earnings report on May 12, 2026.
What were Cellectar Biosciences earnings last quarter?▼
CLRB earnings for the last quarter are 0.65 USD per share, whereas the estimation was -1.22 USD resulting in a +153.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cellectar Biosciences revenue for the last year?▼
Cellectar Biosciences revenue for the last year amounts to 0 USD.
What is Cellectar Biosciences net income for the last year?▼
CLRB net income for the last year is -89.16M USD.
How many employees does Cellectar Biosciences have?▼
As of April 01, 2026, the company has 11 employees.
In which sector is Cellectar Biosciences located?▼
Cellectar Biosciences operates in the Health Care sector.
When did Cellectar Biosciences complete a stock split?▼
The last stock split for Cellectar Biosciences was on June 24, 2025 with a ratio of 1:30.
Where is Cellectar Biosciences headquartered?▼
Cellectar Biosciences is headquartered in Florham Park, US.